Search
Now showing items 1-7 of 7
Clinical evaluation of rosoxacin for the treatment of chancroid
(1986)
One hundred seven men with Haemophilus ducreyi-positive chancroid were assigned to receive 300 mg of rosoxacin as a single dose or 150 mg twice daily for 3 days. Ulcers and buboes were followed clinically and bacteriologicaily ...
Treating chancroid with enoxacin
(1988)
Increasing resistance of Haemophilus ducreyi to antimicrobials necessitates further trials of new antimicrobial agents for treating chancroid. Enoxacin has excellent in vitro activity against H ducreyi, and a randomised ...
Isolation and identification of Haemophilus ducreyi in a clinical laboratory
(University of Nairobi, 1986-09)
Routine procedures used to isolate Haemophilus ducreyi in a busy laboratory are reported. Identification was based on colony morphology and nutritional and biochemical properties of 120 fresh isolates of H. ducreyi. These ...
Comparison of Sheffield media with standard media for the isolation of Haemophilus ducreyi
(1989)
Isolation of Haemophilus ducreyi is the only method for the definitive diagnosis of chancroid. Culture on supplemented gonococcal base (GCHgs) or on supplemented Muller-Hinton agar (MHHb) has yielded the best isolation ...
Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men
(1989)
To determine the frequency and risk factors for female to male sexual transmission of human immunodeficiency virus type 1 (HIV-1), a prospective study was carried out in 422 men who had acquired a sexually transmitted ...
Human immunodeficiency virus infection among men with sexually transmitted diseases. Experience from a center in Africa
(1988)
Heterosexual transmission of the human immunodeficiency virus (HIV) appears to occur readily in Africa but less commonly in North America and Europe. We conducted a case-control study among men attending a clinic for ...
Treatment of gonorrhea with single-dose thiamphenicol in Kenya
(University of Nairobi,, 1984-12)
The efficacy of a single 2.5-g dose of thiamphenicol against infection with penicillinase-producing strains of Neisseria gonorrhoeae (PPNG) or non-penicillinase-producing strains (non-PPNG) was studied in a two-phase ...